Latest International Contracts News

Memphasys secures a follow-up order for its Felix™ sperm selection cartridges from a leading Japanese fertility clinic, marking growing adoption in one of the world’s largest IVF markets and signaling a strategic shift to direct sales.

Rubicon Water has landed four key contracts worth A$8.3 million across the US, Italy, and Australia, marking a strong start to its FY26 sales pipeline and introducing a novel private ESG funding source in the US.

Epsilon Healthcare’s manufacturing arm has secured updated GMP certificates covering domestic and EU/UK markets, reinforcing its quality credentials and paving the way for expanded international contract manufacturing.

icetana Limited reveals delays and payment uncertainties in its Baghdad Safe City project, raising questions about revenue timing and project execution.

DTI Group Ltd reported an 11% revenue increase and secured a $4 million Adelaide Metro contract, alongside a $2.69 million capital raise to fuel growth. The company also deepened global partnerships and enhanced its technology platform during FY25.

Bioxyne Limited projects FY2026 revenue between $65 million and $75 million, driven by expansion in Australian medical cannabis and a landmark $5.8 million contract in Germany.

Beamtree Holdings has landed a $1 million contract with Singapore’s Ministry of Health to audit clinical coding across 20 hospitals, leveraging its AI-driven software platforms. This win underscores Beamtree’s growing international footprint in healthcare data quality.

Ava Risk Group reported a 5% revenue increase to $31.7 million in FY2025, achieving a significant turnaround to $2.1 million underlying EBITDA. The company expanded its Aura Ai-X technology into new sectors and regions despite some order delays.

Aeris Environmental reported a robust 62% revenue increase in the June 2025 quarter, driven by new international contracts and expanding adoption of its Syncromesh IoT platform.

archTIS has reported a standout March quarter with record annual recurring revenue, improved gross margins, and strategic growth through the Direktiv acquisition and new international contracts.

Acusensus has secured major contract expansions across Australia and New Zealand, driving a 15.8% revenue increase in Q2 FY25 and bolstering its cash reserves to $30.3 million. The company’s strategic international push and innovative enforcement technologies position it for sustained growth.